Walleye Trading
VNDA icon

Walleye Trading’s Vanda Pharmaceuticals VNDA Stock Holding History

Walleye Trading’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,072
Closed -$53.6K – 5593
2022
Q2 		$55K Sell
5,072
-5,332
-51% -$55.2K ﹤0.01% 4302
2022
Q1 		$118K Buy
+10,404
New +$137K ﹤0.01% 4154
2021
Q4 		– Sell
-14,039
Closed -$245K – 5927
2021
Q3 		$241K Sell
14,039
-7,578
-35% -$133K ﹤0.01% 3676
2021
Q2 		$465K Buy
+21,617
New +$387K ﹤0.01% 2997
2020
Q1 		– Sell
-1,088
Closed -$18K – 4630
2019
Q4 		$18K Buy
+1,088
New +$16.4K ﹤0.01% 4001
2019
Q1 		– Sell
-8,380
Closed -$219K – 4808
2018
Q4 		$219K Buy
+8,380
New +$197K ﹤0.01% 3311
2017
Q2 		– Sell
-400
Closed -$6 – 4978
2017
Q1 		$6 Sell
400
-31,600
-99% -$450K ﹤0.01% 4430
2016
Q4 		$510K Buy
32,000
+31,600
+7,900% +$508K ﹤0.01% 2062
2016
Q3 		$7K Buy
+400
New +$5.38K ﹤0.01% 4498
2016
Q2 		– Sell
-4,500
Closed -$38K – 5752
2016
Q1 		$38K Buy
+4,500
New +$36.9K ﹤0.01% 4068

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Walleye Trading's VNDA Position: Q3 2022 in Review

Walleye Trading sold out of Vanda Pharmaceuticals (VNDA) in Q3 2022, closing a stake of 5,072 shares — an estimated $53.6K sold.

Walleye Trading first reported a position in VNDA in Q1 2016 and held it in 10 quarters. The position peaked at $510K in Q4 2016. 178 funds tracked by Wall St. Rank hold VNDA as of Q3 2022.

  • Walleye Trading reported no remaining Vanda Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Walleye Trading sold 5,072 Vanda Pharmaceuticals shares in Q3 2022, an estimated $53.6K.
  • Walleye Trading first reported a position in Vanda Pharmaceuticals in Q1 2016 and held it in 10 quarters.
  • Walleye Trading's Vanda Pharmaceuticals position peaked at $510K in Q4 2016.
  • 178 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2022.

Based on Walleye Trading's 13F filing for Q3 2022, filed 14 Nov 2022.